636 related articles for article (PubMed ID: 19021619)
21. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
22. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of amitriptyline treatment for interstitial cystitis.
Hertle L; van Ophoven A
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S61-5. PubMed ID: 20094958
[TBL] [Abstract][Full Text] [Related]
24. Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement.
Nickel JC; Kaufman DM; Zhang HF; Wan GJ; Sand PK
Urology; 2008 Jan; 71(1):57-61. PubMed ID: 18242365
[TBL] [Abstract][Full Text] [Related]
25. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
Dinsmore WW; Wyllie MG
BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
[TBL] [Abstract][Full Text] [Related]
26. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
Nickel JC; Hanno P; Kumar K; Thomas H
Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
[TBL] [Abstract][Full Text] [Related]
27. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
Apostolidis A; Gonzales GE; Fowler CJ
Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
[TBL] [Abstract][Full Text] [Related]
28. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
29. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
30. Hyperbaric oxygen for the treatment of interstitial cystitis: long-term results of a prospective pilot study.
van Ophoven A; Rossbach G; Oberpenning F; Hertle L
Eur Urol; 2004 Jul; 46(1):108-13. PubMed ID: 15183555
[TBL] [Abstract][Full Text] [Related]
31. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
Peng CH; Kuo HC
Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.
Mayer R; Propert KJ; Peters KM; Payne CK; Zhang Y; Burks D; Culkin DJ; Diokno A; Hanno P; Landis JR; Madigan R; Messing EM; Nickel JC; Sant GR; Warren J; Wein AJ; Kusek JW; Nyberg LM; Foster HE;
J Urol; 2005 Apr; 173(4):1186-91. PubMed ID: 15758738
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on it.
Sairanen J; Leppilahti M; Tammela TL; Paananen I; Aaltomaa S; Taari K; Ruutu M
Scand J Urol Nephrol; 2009; 43(3):212-9. PubMed ID: 19137459
[TBL] [Abstract][Full Text] [Related]
34. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
35. Responsiveness of symptom scales for interstitial cystitis.
Propert KJ; Mayer RD; Wang Y; Sant GR; Hanno PM; Peters KM; Kusek JW;
Urology; 2006 Jan; 67(1):55-9. PubMed ID: 16413332
[TBL] [Abstract][Full Text] [Related]
36. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.
Bosch PC
J Urol; 2014 Jan; 191(1):77-82. PubMed ID: 23792149
[TBL] [Abstract][Full Text] [Related]
37. Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis.
Parsons CL; Zupkas P; Proctor J; Koziol J; Franklin A; Giesing D; Davis E; Lakin CM; Kahn BS; Garner WJ
J Sex Med; 2012 Jan; 9(1):207-12. PubMed ID: 22082303
[TBL] [Abstract][Full Text] [Related]
38. [Painful bladder syndrome in interstitial cystitis: relation between symptoms, endoscopy and biopsia results and the treatment effects].
Zámecník L; Hanus T; Pavlík I
Cas Lek Cesk; 2007; 146(10):801-5. PubMed ID: 18020015
[TBL] [Abstract][Full Text] [Related]
39. Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms.
Parsons CL; Koziol JA; Proctor JG; Zupkas P; Argade S
Can J Urol; 2015 Apr; 22(2):7739-44. PubMed ID: 25891339
[TBL] [Abstract][Full Text] [Related]
40. Severity of interstitial cystitis symptoms and quality of life in female patients.
El Khoudary SR; Talbott EO; Bromberger JT; Chang CC; Songer TJ; Davis EL
J Womens Health (Larchmt); 2009 Sep; 18(9):1361-8. PubMed ID: 19743907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
